Macro‐and microvascular endothelial dysfunction in diabetes: 糖尿病诱导的内皮细胞功能损伤
Y Shi, PM Vanhoutte - Journal of diabetes, 2017 - Wiley Online Library
血管内皮细胞和内皮细胞释放的活性因子是调控血管舒张功能的重要因素. 糖尿病是慢性心血管
疾病的高危因素之一. 目前认为高糖和糖尿病引起的内皮细胞功能障碍是造成血管功能改变 …
疾病的高危因素之一. 目前认为高糖和糖尿病引起的内皮细胞功能障碍是造成血管功能改变 …
New insights into RhoA/Rho-kinase signaling: a key regulator of vascular contraction
KP Nunes, RC Webb - Small GTPases, 2021 - Taylor & Francis
While Rho-signalling controlling vascular contraction is a canonical mechanism, with the
modern approaches used in research, we are advancing our understanding and details into …
modern approaches used in research, we are advancing our understanding and details into …
[HTML][HTML] Advanced glycation end-products regulate extracellular matrix-adipocyte metabolic crosstalk in diabetes
C Strieder-Barboza, NA Baker, CG Flesher… - Scientific reports, 2019 - nature.com
The adipose tissue extracellular matrix (ECM) regulates adipocyte cellular metabolism and
is altered in obesity and type 2 diabetes, but mechanisms underlying ECM-adipocyte …
is altered in obesity and type 2 diabetes, but mechanisms underlying ECM-adipocyte …
[HTML][HTML] New Mechanisms to Prevent Heart Failure with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic …
This review examines the impact of obesity on the pathophysiology of heart failure with
preserved ejection fraction (HFpEF) and focuses on novel mechanisms for HFpEF …
preserved ejection fraction (HFpEF) and focuses on novel mechanisms for HFpEF …
Biomarkers in metabolic syndrome
YH Cho, Y Lee, JI Choi, SR Lee, SY Lee - Advances in Clinical Chemistry, 2022 - Elsevier
Metabolic syndrome (MetS) is a global health challenge characterized as a group of risk
factors for developing atherosclerotic cardiovascular disease. Although visceral adipose …
factors for developing atherosclerotic cardiovascular disease. Although visceral adipose …
The pleiotropic effects of antithrombotic drugs in the metabolic–cardiovascular–neurodegenerative disease continuum: Impact beyond reduced clotting
Antithrombotic drugs are widely used for primary and secondary prevention, as well as
treatment of many cardiovascular disorders. Over the past few decades, major advances in …
treatment of many cardiovascular disorders. Over the past few decades, major advances in …
Interruption of perivascular and perirenal adipose tissue thromboinflammation rescues prediabetic cardioautonomic and renovascular deterioration
A Al-Saidi, IF Alzaim, SH Hammoud, G Al Arab… - Clinical …, 2024 - portlandpress.com
The cardiovascular and renovascular complications of metabolic deterioration are
associated with localized adipose tissue dysfunction. We have previously demonstrated that …
associated with localized adipose tissue dysfunction. We have previously demonstrated that …
[HTML][HTML] Salidroside prevents diabetes‑induced cognitive impairment via regulating the Rho pathway
X Hao, J Yuan, H Dong - Molecular Medicine Reports, 2019 - spandidos-publications.com
In previous years, it has been found that Rhodiola has a wide range of pharmacological
effects in diseases of the cardiovascular system, as it can remove superoxide anions and …
effects in diseases of the cardiovascular system, as it can remove superoxide anions and …
Role of exosome-derived miRNAs in diabetic wound angiogenesis
WT Chen, Y Luo, XM Chen, JH Xiao - Molecular and Cellular Biochemistry, 2023 - Springer
Chronic wounds with high disability are among the most common and serious complications
of diabetes. Angiogenesis dysfunction impair wound healing in patients with diabetes …
of diabetes. Angiogenesis dysfunction impair wound healing in patients with diabetes …
RhoA/rho kinase pathway activation in age‐associated endothelial cell dysfunction and thrombosis
Abstract The small GTPase RhoA and the downstream Rho kinase (ROCK) regulate several
cell functions and pathological processes in the vascular system that contribute to the age …
cell functions and pathological processes in the vascular system that contribute to the age …